Study on the mechanism of Top1 and its signaling pathway in asthma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200062059

Enrollment

Unknown

Registered

2022-07-21

Start date

2022-07-20

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

children with asthma:no

control:no

Eligibility

Sex/Gender

All

Age

3 Years to 14 Years

Inclusion criteria

Inclusion criteria: The criteria for the diagnosis of asthma in children were in accordance with the guidelines for the diagnosis, prevention and treatment of bronchial asthma in children (2016 Edition).

Exclusion criteria

Exclusion criteria: Combined with genetic diseases, immune diseases.

Design outcomes

Primary

Measure	Time frame
Top1 gene expression;Eosinophil;	—

Secondary

Measure	Time frame
total IgE;	—

Countries

China

Contacts

Public ContactCai Xulong

271339044@qq.com+86 15722569989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026